Stock Evaluator: Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. AMIX
$5.29
0.02
0.38%
August 21, 2026 1:36:00 PM
EST
Volume: 78,060
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company’s technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Financial Summary
| Share Statistics | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.1 | $407.7 | 3% |
|
| Shares Out (Mil) | 0.5 | 41.3 | 3% |
|
| Institutional Ownership | 77.3% | 81.4% | 47% |
|
| Float (Mil) | 0.5 | 34.9 | 1% |
|
| Beta | -1.16 | 0.88 | 1% |
|
| Avg Daily Volume (000s) | 288 | 412 | 49% |
|
| Price Change (52-week) |
(76.3%) | 64.8% | 7% |
|
| Growth | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (6.0%) | na |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (16.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $119 | na |
|
| Net Income (TTM) (Mil) | ($16) | ($9) | 26% |
|
| EPS (TTM) | ($36.372) | ($0.400) | 1% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | ($3) | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $21 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1 | $427 | 4% |
|
| Valuation | AMIX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.90 | 3.06 | 18% |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | AMIX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 58.9% | na |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (248.2%) | (12.7%) | 1% |
|
| ROE | (316.0%) | (13.1%) | 3% |
|
| Liabilities to Assets | 20.6% | 46.0% | 14% |
|
| F-Score | 2 | 4 | 7% |
|
Autonomix Medical, Inc. did not pass any screens on 8/20/2026.
